Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%
MT Newswires Live
Oct 15, 2025
Proteomics International Laboratories (ASX:PIQ) secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in Victoria, according to a Wednesday filing with the Australian bourse.
The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.
PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.
Shares rose nearly 3% in morning trade on Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.